Latest Breaking News On - Satish reddy - Page 54 : comparemela.com

COVID-19 patients: Dr Reddy Labs launches 2-DG oral anti-COVID drug commercially

Synopsis In the initial weeks, the company will make the drug available in hospitals across metros and tier I cities, and subsequently expand coverage to the rest of India. The price for the drug has been pegged at Rs. 990 for private procurements while for government supply, a subsidized rate will be offered. Agencies It can be administered only upon prescription and under the supervision of a qualified physician to hospitalised moderate to severe COVID-19 patients as an adjunct therapy to the existing standard of care. Drug major Dr Reddy s Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet.

Andhra pradeshG satheesh reddySatish reddyInstitute of nuclear medicine allied sciencesDepartment of defenceDr reddy laboratories ltdNuclear medicineAllied sciencesSecretary departmentஆந்திரா பிரதேஷ்க் சதீஷ் சிவப்புசத்தீஷ் சிவப்புநிறுவனம் ஆஃப் அணு மருந்து கூட்டணி அறிவியல்துறை ஆஃப் பாதுகாப்புடாக்டர் சிவப்பு ஆய்வகங்கள் லிமிடெட்அணு மருந்து

Dr Reddy s announces commercial launch of 2-DG

Updated: MRP of each sachet ₹990, to be offered at subsidised rate to govt institutions Share Article AAA An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of DRDO, in collaboration with Dr Reddy’s Laboratories, Hyderabad. The drug will help in faster recovery of Covid-19 patients. Twitter/@DRDO India MRP of each sachet ₹990, to be offered at subsidised rate to govt institutions Drugmaker Dr. Reddy’s Laboratories has announced the commercial launch of 2-deoxy-D-glucose (2-DG), an oral drug for use as an adjunct therapy for hospitalised COVID-19 patients. The maximum retail price is ₹990 per sachet. It will be made available at a subsidised rate to government institutions, the company said, adding its 2-DG has a purity of 99.5%.

Andhra pradeshG satheesh reddySatish reddyInstitute of nuclear medicine allied sciencesNuclear medicineAllied sciencesChairman satish reddyஆந்திரா பிரதேஷ்க் சதீஷ் சிவப்புசத்தீஷ் சிவப்புநிறுவனம் ஆஃப் அணு மருந்து கூட்டணி அறிவியல்அணு மருந்துகூட்டணி அறிவியல்தலைவர் சத்தீஷ் சிவப்பு

Dr Reddy s Laboratories announces commercial launch of anti-COVID-19 drug 2-DG

Dr Reddy s Laboratories announces commercial launch of anti-COVID-19 drug 2-DG
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

Andhra pradeshG satheesh reddySatish reddyReddy laboratories limited onUnion health ministryInstitute of nuclear medicine allied sciencesDevelopment organisationDefence researchDepartment of defenceLaboratories limitedMaximum retail priceNuclear medicineAllied sciencesSecretary departmentஆந்திரா பிரதேஷ்க் சதீஷ் சிவப்பு

Dr Reddy s Announces Commercial Launch Of Covid Drug 2-DG, Caps Price

Dr Reddy s Announces Commercial Launch Of Covid Drug 2-DG, Caps Price
ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.

Satish reddyAnnounces commercial launch of covid drugCaps priceசத்தீஷ் சிவப்புதொப்பிகள் ப்ரைஸ்

DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients

DRL launches DRDO drug 2-DG to treat moderate to severe Covid patients
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshG satheesh reddySatish reddyInstitute of nuclear medicine allied sciencesDevelopment organisationDepartment of defenceDefence researchNuclear medicineAllied sciencesஆந்திரா பிரதேஷ்க் சதீஷ் சிவப்புசத்தீஷ் சிவப்புநிறுவனம் ஆஃப் அணு மருந்து கூட்டணி அறிவியல்வளர்ச்சி ஆர்கநைஸேஶந்துறை ஆஃப் பாதுகாப்புபாதுகாப்பு ஆராய்ச்சி